SIGA Technologies, Inc. (SIGA) 10-Year Financial Performance & Capital Metrics

SIGA • • Industrial / General

HealthcareSpecialty & Generic PharmaSpecialty PharmaceuticalsInfectious Disease Therapeutics

AboutSIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.Show more

Revenue $139M -0.9%
EBITDA $71M -16.2%
Net Income $59M -13.0%
EPS (Diluted) 0.83 -12.6%
Gross Margin 77.44% -11.2%
EBITDA Margin 50.84% -15.5%
Operating Margin 50.45% -15.6%
Net Margin 42.69% -12.3%
ROE 28.7% -22.6%
ROIC 96.99% -7.8%
Debt/Equity 0.00 -11.6%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Excellent 3Y average ROE of 28.5%
✓FCF machine: 35.1% free cash flow margin
✓Strong 5Y sales CAGR of 39.0%
✓Healthy 5Y average net margin of 43.8%

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y46.06%

5Y38.99%

3Y1.24%

TTM-0.85%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-5.18%

TTM-13.11%

EPS CAGR

10Y-

5Y-

3Y-3.02%

TTM-14.47%

ROCE

10Y Avg38.88%

5Y Avg45.14%

3Y Avg34%

Latest33.39%

Peer Comparison

Infectious Disease Therapeutics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SIGASIGA Technologies, Inc.	473.35M	6.61	7.96	-0.86%	43.23%	36.6%	10.29%	0.00
SCYXSCYNEXIS, Inc.	26.94M	0.64	-1.46	-97.33%	-8.63%	-69.45%		0.30

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	8.18M	14.99M	12.27M	477.05M	26.74M	124.96M	133.67M	110.78M	139.92M	138.72M
Revenue Growth %	1.6%	0.83%	-0.18%	37.88%	-0.94%	3.67%	0.07%	-0.17%	0.26%	-0.01%
Cost of Goods Sold+	13.13M	19.71M	16.68M	108.29M	15.09M	25.74M	16.6M	10.43M	17.83M	31.29M
COGS % of Revenue	1.61%	1.32%	1.36%	0.23%	0.56%	0.21%	0.12%	0.09%	0.13%	0.23%
Gross Profit+	-4.95M	-4.72M	-4.41M	368.77M	11.66M	99.22M	117.07M	100.34M	122.09M	107.43M
Gross Margin %	-0.61%	-0.32%	-0.36%	0.77%	0.44%	0.79%	0.88%	0.91%	0.87%	0.77%
Gross Profit Growth %	0.36%	0.05%	0.07%	84.61%	-0.97%	7.51%	0.18%	-0.14%	0.22%	-0.12%
Operating Expenses+	11.59M	14.62M	13.21M	13.67M	13.98M	14.72M	27.98M	57.64M	38.47M	37.45M
OpEx % of Revenue	1.42%	0.98%	1.08%	0.03%	0.52%	0.12%	0.21%	0.52%	0.27%	0.27%
Selling, General & Admin	10.58M	13.71M	12.3M	12.88M	13.25M	14.72M	18.03M	35.12M	22.04M	25.14M
SG&A % of Revenue	1.29%	0.91%	1%	0.03%	0.5%	0.12%	0.13%	0.32%	0.16%	0.18%
Research & Development	13.13M	19.71M	16.68M	13.02M	0	0	9.94M	22.53M	16.43M	12.31M
R&D % of Revenue	1.61%	1.32%	1.36%	0.03%	-	-	0.07%	0.2%	0.12%	0.09%
Other Operating Expenses	42.2K	-1.66M	16.79K	78.94M	726.11K	0	0	0	0	0
Operating Income+	-30.95M	-31.01M	-18.85M	355.1M	-2.32M	84.5M	89.09M	42.7M	83.62M	69.98M
Operating Margin %	-3.79%	-2.07%	-1.54%	0.74%	-0.09%	0.68%	0.67%	0.39%	0.6%	0.5%
Operating Income Growth %	0.85%	-0%	0.39%	19.84%	-1.01%	37.39%	0.05%	-0.52%	0.96%	-0.16%
EBITDA+	-30.71M	-30.84M	-18.72M	355.17M	-1.8M	85.03M	89.62M	43.22M	84.16M	70.52M
EBITDA Margin %	-3.76%	-2.06%	-1.53%	0.74%	-0.07%	0.68%	0.67%	0.39%	0.6%	0.51%
EBITDA Growth %	0.85%	-0%	0.39%	19.98%	-1.01%	48.37%	0.05%	-0.52%	0.95%	-0.16%
D&A (Non-Cash Add-back)	247.36K	174.28K	132.19K	69.63K	527K	529.81K	522.37K	517.64K	538.29K	538.42K
EBIT	-38.72M	-25.62M	-23.57M	427.12M	5.59M	76.53M	89.09M	42.7M	83.62M	69.98M
Net Interest Income+	-266.73K	-14.06M	-14.76M	-15.48M	-15.77M	-3.02M	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	266.73K	14.06M	14.76M	15.48M	15.77M	3.02M	0	0	0	0
Other Income/Expense	-8.04M	-8.67M	-19.48M	56.54M	-7.86M	-10.99M	218.94K	1.43M	4.16M	6.09M
Pretax Income+	-38.99M	-39.68M	-38.33M	411.64M	-10.18M	73.51M	89.31M	44.13M	87.78M	76.07M
Pretax Margin %	-4.77%	-2.65%	-3.12%	0.86%	-0.38%	0.59%	0.67%	0.4%	0.63%	0.55%
Income Tax+	461.98K	13.88K	-2.09M	-10.17M	-2.94M	17.17M	19.86M	10.23M	19.71M	16.86M
Effective Tax Rate %	1.01%	1%	0.95%	1.02%	0.71%	0.77%	0.78%	0.77%	0.78%	0.78%
Net Income+	-39.45M	-39.7M	-36.24M	421.81M	-7.24M	56.34M	69.45M	33.9M	68.07M	59.21M
Net Margin %	-4.83%	-2.65%	-2.95%	0.88%	-0.27%	0.45%	0.52%	0.31%	0.49%	0.43%
Net Income Growth %	0.85%	-0.01%	0.09%	12.64%	-1.02%	8.78%	0.23%	-0.51%	1.01%	-0.13%
Net Income (Continuing)	-39.45M	-39.7M	-36.24M	421.81M	-7.24M	56.34M	69.45M	33.9M	68.07M	59.21M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.73	-0.69	-0.46	5.10	-0.09	0.71	0.91	0.46	0.95	0.83
EPS Growth %	0.85%	0.05%	0.33%	12.09%	-1.02%	9.06%	0.28%	-0.49%	1.07%	-0.13%
EPS (Basic)	-0.73	-0.69	-0.46	5.28	-0.09	0.71	0.92	0.46	0.95	0.83
Diluted Shares Outstanding	53.78M	57.19M	78.87M	82.71M	82.18M	79.44M	76.4M	73.55M	71.68M	71.77M
Basic Shares Outstanding	53.78M	57.19M	78.77M	79.92M	81.03M	79.26M	75.32M	72.93M	71.36M	71.25M
Dividend Payout Ratio	-	-	-	-	-	-	-	0.97%	0.47%	0.72%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	129.46M	69.16M	37.36M	121.29M	180.04M	143.61M	208.75M	185.79M	238.99M	231.04M
Cash & Short-Term Investments	112.71M	28.7M	19.86M	100.65M	65.25M	117.89M	103.14M	98.79M	150.15M	155.4M
Cash Only	112.71M	28.7M	19.86M	100.65M	65.25M	117.89M	103.14M	98.79M	150.15M	155.4M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	3.68M	3.15M	1.8M	1.96M	4.17M	3.34M	83.65M	45.41M	21.13M	21.17M
Days Sales Outstanding	164.14	76.82	53.61	1.5	56.89	9.76	228.42	149.61	55.12	55.69
Inventory	12.45M	26.21M	2.98M	2.91M	9.65M	20.27M	19.51M	39.27M	64.22M	49.56M
Days Inventory Outstanding	346	485.35	65.28	9.8	233.55	287.41	428.94	1.37K	1.31K	578.18
Other Current Assets	0	10.14M	10.7M	11.45M	95.74M	0	0	2.32M	3.5M	4.91M
Total Non-Current Assets+	56.27M	91.82M	107.31M	82.15M	18.52M	6.22M	5.97M	9.25M	15.36M	13.29M
Property, Plant & Equipment	449.82K	299.48K	138.64K	171.27K	2.62M	2.1M	2.37M	1.85M	1.33M	1.3M
Fixed Asset Turnover	18.18x	50.05x	88.50x	2785.33x	10.21x	59.39x	56.50x	59.93x	105.07x	106.84x
Goodwill	898.33K	898.33K	898.33K	898.33K	898.33K	898.33K	898.33K	898.33K	898.33K	898.33K
Intangible Assets	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	-212.71M	-213.42M	96.59M	68.29M	0	0	0	0	0	0
Other Non-Current Assets	1.99M	17.98M	7.24M	1.06M	856.77K	676.92K	286.58K	252.55K	2.08M	240.68K
Total Assets+	185.73M	160.98M	144.67M	203.44M	198.57M	149.83M	214.73M	195.04M	254.35M	244.34M
Asset Turnover	0.04x	0.09x	0.08x	2.34x	0.13x	0.83x	0.62x	0.57x	0.55x	0.57x
Asset Growth %	0.12%	-0.13%	-0.1%	0.41%	-0.02%	-0.25%	0.43%	-0.09%	0.3%	-0.04%
Total Current Liabilities+	7.33M	13.83M	6.81M	11.34M	91.74M	10.48M	30.49M	21.52M	54.12M	25.33M
Accounts Payable	3.94M	2.52M	1.33M	1.69M	3.05M	1.28M	2.03M	3.36M	1.46M	1.34M
Days Payables Outstanding	109.65	46.61	29.08	5.69	73.89	18.13	44.59	117.39	29.82	15.64
Short-Term Debt	0	0	0	0	80.04M	0	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	1.98M	8.69M	1.36M	5.03M	3.61M	3.42M	4.24M	3.66M	6.82M	3.07M
Current Ratio	17.65x	5.00x	5.49x	10.70x	1.96x	13.70x	6.85x	8.63x	4.42x	9.12x
Quick Ratio	15.96x	3.11x	5.05x	10.44x	1.86x	11.77x	6.21x	6.81x	3.23x	7.16x
Cash Conversion Cycle	400.5	515.56	89.82	5.61	216.54	279.04	612.77	1.41K	1.34K	618.24
Total Non-Current Liabilities+	462.83M	434.57M	461M	89.19M	9.05M	9.55M	9.92M	3.36M	3.38M	3.2M
Long-Term Debt	0	66.55M	71.05M	75.55M	0	0	0	0	0	0
Capital Lease Obligations	0	-26.84M	0	0	0	0	0	0	0	0
Deferred Tax Liabilities	265.64K	286.07K	11.47M	479.41K	0	0	0	0	0	0
Other Non-Current Liabilities	207.3M	-26.59M	12.31M	13.64M	9.05M	9.55M	9.92M	3.36M	3.38M	3.2M
Total Liabilities	470.16M	448.4M	467.81M	100.53M	100.78M	20.04M	40.41M	24.88M	57.49M	28.53M
Total Debt+	0	66.55M	71.05M	75.55M	80.46M	449.94K	466.83K	528.17K	564.01K	546.82K
Net Debt	-112.71M	37.85M	51.19M	-25.11M	15.22M	-117.44M	-102.67M	-98.26M	-149.58M	-154.85M
Debt / Equity	-	-	-	0.73x	0.82x	0.00x	0.00x	0.00x	0.00x	0.00x
Debt / EBITDA	-	-	-	0.21x	-	0.01x	0.01x	0.01x	0.01x	0.01x
Net Debt / EBITDA	-	-	-	-0.07x	-	-1.38x	-1.15x	-2.27x	-1.78x	-2.20x
Interest Coverage	-116.05x	-2.21x	-1.28x	22.94x	-0.15x	28.01x	-	-	-	-
Total Equity+	-284.43M	-287.42M	-323.14M	102.91M	97.78M	129.79M	174.31M	170.16M	196.86M	215.8M
Equity Growth %	-0.15%	-0.01%	-0.12%	1.32%	-0.05%	0.33%	0.34%	-0.02%	0.16%	0.1%
Book Value per Share	-5.29	-5.03	-4.10	1.24	1.19	1.63	2.28	2.31	2.75	3.01
Total Shareholders' Equity	-284.43M	-287.42M	-323.14M	102.91M	97.78M	129.79M	174.31M	170.16M	196.86M	215.8M
Common Stock	5.41K	7.87K	7.9K	8.08K	8.13K	7.72K	7.35K	7.27K	7.11K	7.14K
Retained Earnings	-461.44M	-501.14M	-537.38M	-115.79M	-123.03M	-95.19M	-51.76M	-63.8M	-38.94M	-22.84M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-3.3M	-3.47M	-3.35M	-3.24M	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	11.11M	-115.59M	-8.16M	68.87M	-18.2M	71.52M	11.49M	41.61M	94.8M	48.76M
Operating CF Margin %	1.36%	-7.71%	-0.66%	0.14%	-0.68%	0.57%	0.09%	0.38%	0.68%	0.35%
Operating CF Growth %	-0.22%	-11.4%	0.93%	9.44%	-1.26%	4.93%	-0.84%	2.62%	1.28%	-0.49%
Net Income	-39.45M	-39.7M	-36.24M	421.81M	-7.24M	56.34M	69.45M	33.9M	68.07M	59.21M
Depreciation & Amortization	247.36K	174.28K	132.19K	69.63K	527K	529.81K	522.37K	517.64K	538.29K	538.42K
Stock-Based Compensation	1.57M	775.54K	1.1M	2.27M	2.11M	1.35M	1.27M	1.78M	2.05M	3.64M
Deferred Taxes	243.71K	2.66M	-2.72M	-9.3M	-2.42M	11.61M	121.45K	-3.83M	-4.8M	193.42K
Other Non-Cash Items	10.05K	1.79M	21.23M	-348.87M	-593.99K	9.39M	501K	-199.19K	579.24K	-10.13M
Working Capital Changes	48.49M	-81.29M	8.34M	2.89M	-10.59M	-7.7M	-60.37M	9.44M	28.36M	-4.69M
Change in Receivables	-3.19M	522.36K	1.35M	-49.72K	-2.21M	827.73K	-80.31M	38.24M	24.28M	-35.18K
Change in Inventory	6.6M	-13.76M	22.69M	39	-6.74M	-8.01M	136.37K	-19.96M	-25.52M	15.34M
Change in Payables	1.86M	-177.34K	-1.85M	1.62M	936.84K	-2.2M	1.47M	2.07M	2M	-5.74M
Cash from Investing+	3.89M	1.19M	-100.12K	78.24M	-29.09K	-15.5K	-50.62K	0	-21.69K	-42.45K
Capital Expenditures	-108.95K	-23.93K	-100.12K	-102.26K	-29.09K	-15.5K	-50.62K	0	-21.69K	-42.45K
CapEx % of Revenue	0.01%	0%	0.01%	0%	0%	0%	0%	-	0%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	4M	1.21M	0	78.34M	0	0	0	0	0	0
Cash from Financing+	-2M	30.39M	-585.57K	-3.81M	-1.18M	-114.6M	-26.2M	-45.96M	-43.42M	-43.46M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	-32.94M	-32.14M	-42.67M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-3.33K	-32.9M	5.5K	-3.81M	-1.18M	-184.02K	-173.92K	-12.53K	-214.79K	-799.89K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	11M	-115.61M	-8.26M	68.77M	-18.23M	71.5M	11.44M	41.61M	94.78M	48.72M
FCF Margin %	1.35%	-7.71%	-0.67%	0.14%	-0.68%	0.57%	0.09%	0.38%	0.68%	0.35%
FCF Growth %	-0.22%	-11.51%	0.93%	9.33%	-1.27%	4.92%	-0.84%	2.64%	1.28%	-0.49%
FCF per Share	0.20	-2.02	-0.10	0.83	-0.22	0.90	0.15	0.57	1.32	0.68
FCF Conversion (FCF/Net Income)	-0.28x	2.91x	0.23x	0.16x	2.51x	1.27x	0.17x	1.23x	1.39x	0.82x
Interest Paid	0	11.67M	10.29M	0	0	0	0	0	0	0
Taxes Paid	0	500.98K	325K	251.96K	0	3.72M	1.06M	31.37M	3.5M	30.36M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-	409.86%	-7.22%	49.51%	45.68%	19.68%	37.09%	28.7%
Return on Invested Capital (ROIC)	-	-	-	342.28%	-1.83%	101.12%	159.1%	44.62%	105.25%	96.99%
Gross Margin	-60.6%	-31.51%	-35.95%	77.3%	43.59%	79.4%	87.58%	90.58%	87.26%	77.44%
Net Margin	-482.53%	-264.87%	-295.34%	88.42%	-27.08%	45.09%	51.96%	30.61%	48.65%	42.69%
Debt / Equity	-	-	-	0.73x	0.82x	0.00x	0.00x	0.00x	0.00x	0.00x
Interest Coverage	-116.05x	-2.21x	-1.28x	22.94x	-0.15x	28.01x	-	-	-	-
FCF Conversion	-0.28x	2.91x	0.23x	0.16x	2.51x	1.27x	0.17x	1.23x	1.39x	0.82x
Revenue Growth	160.39%	83.32%	-18.14%	3788.3%	-94.39%	367.28%	6.97%	-17.13%	26.31%	-0.86%

Revenue by Segment

	2018	2019	2022	2023	2024
Product Sales and Supportive Services	468.92M	11.19M	86.66M	130.67M	133.33M
Product Sales and Supportive Services Growth	-	-97.61%	674.45%	50.78%	2.04%
Research and Development	8.14M	15.55M	24.11M	9.25M	5.39M
Research and Development Growth	-	91.17%	55.05%	-61.64%	-41.73%

Revenue by Geography

	2018	2019	2022	2023	2024
UNITED STATES	-	-	39.8M	118.65M	115.74M
UNITED STATES Growth	-	-	-	198.09%	-2.45%
Non-US	-	-	70.97M	21.27M	22.98M
Non-US Growth	-	-	-	-70.03%	8.03%
Asia Pacific	-	-	14.85M	966.63K	13.86M
Asia Pacific Growth	-	-	-	-93.49%	1333.54%
EMEA	-	-	16.27M	20.3M	8.38M
EMEA Growth	-	-	-	24.77%	-58.72%
CANADA	-	-	38.88M	-	737.68K
CANADA Growth	-	-	-	-	-
Other	-	-	972.8K	-	-
Other Growth	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

SIGA Technologies, Inc. (SIGA) has a price-to-earnings (P/E) ratio of 8.0x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

SIGA Technologies, Inc. (SIGA) reported $172.2M in revenue for fiscal year 2024. This represents a 1254% increase from $12.7M in 2011.

SIGA Technologies, Inc. (SIGA) saw revenue decline by 0.9% over the past year.

Yes, SIGA Technologies, Inc. (SIGA) is profitable, generating $74.5M in net income for fiscal year 2024 (42.7% net margin).

Dividend & Returns

Yes, SIGA Technologies, Inc. (SIGA) pays a dividend with a yield of 8.99%. This makes it attractive for income-focused investors.

SIGA Technologies, Inc. (SIGA) has a return on equity (ROE) of 28.7%. This is excellent, indicating efficient use of shareholder capital.

SIGA Technologies, Inc. (SIGA) generated $116.3M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

SIGA Technologies, Inc. (SIGA) 10-Year Financial Performance & Capital Metrics

SIGA • • Industrial / General

HealthcareSpecialty & Generic PharmaSpecialty PharmaceuticalsInfectious Disease Therapeutics

Revenue $139M -0.9%
EBITDA $71M -16.2%
Net Income $59M -13.0%
EPS (Diluted) 0.83 -12.6%
Gross Margin 77.44% -11.2%
EBITDA Margin 50.84% -15.5%
Operating Margin 50.45% -15.6%
Net Margin 42.69% -12.3%
ROE 28.7% -22.6%
ROIC 96.99% -7.8%
Debt/Equity 0.00 -11.6%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Excellent 3Y average ROE of 28.5%
✓FCF machine: 35.1% free cash flow margin
✓Strong 5Y sales CAGR of 39.0%
✓Healthy 5Y average net margin of 43.8%

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y46.06%

5Y38.99%

3Y1.24%

TTM-0.85%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-5.18%

TTM-13.11%

EPS CAGR

10Y-

5Y-

3Y-3.02%

TTM-14.47%

ROCE

10Y Avg38.88%

5Y Avg45.14%

3Y Avg34%

Latest33.39%

Peer Comparison

Infectious Disease Therapeutics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SIGASIGA Technologies, Inc.	473.35M	6.61	7.96	-0.86%	43.23%	36.6%	10.29%	0.00
SCYXSCYNEXIS, Inc.	26.94M	0.64	-1.46	-97.33%	-8.63%	-69.45%		0.30

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	8.18M	14.99M	12.27M	477.05M	26.74M	124.96M	133.67M	110.78M	139.92M	138.72M
Revenue Growth %	1.6%	0.83%	-0.18%	37.88%	-0.94%	3.67%	0.07%	-0.17%	0.26%	-0.01%
Cost of Goods Sold+	13.13M	19.71M	16.68M	108.29M	15.09M	25.74M	16.6M	10.43M	17.83M	31.29M
COGS % of Revenue	1.61%	1.32%	1.36%	0.23%	0.56%	0.21%	0.12%	0.09%	0.13%	0.23%
Gross Profit+	-4.95M	-4.72M	-4.41M	368.77M	11.66M	99.22M	117.07M	100.34M	122.09M	107.43M
Gross Margin %	-0.61%	-0.32%	-0.36%	0.77%	0.44%	0.79%	0.88%	0.91%	0.87%	0.77%
Gross Profit Growth %	0.36%	0.05%	0.07%	84.61%	-0.97%	7.51%	0.18%	-0.14%	0.22%	-0.12%
Operating Expenses+	11.59M	14.62M	13.21M	13.67M	13.98M	14.72M	27.98M	57.64M	38.47M	37.45M
OpEx % of Revenue	1.42%	0.98%	1.08%	0.03%	0.52%	0.12%	0.21%	0.52%	0.27%	0.27%
Selling, General & Admin	10.58M	13.71M	12.3M	12.88M	13.25M	14.72M	18.03M	35.12M	22.04M	25.14M
SG&A % of Revenue	1.29%	0.91%	1%	0.03%	0.5%	0.12%	0.13%	0.32%	0.16%	0.18%
Research & Development	13.13M	19.71M	16.68M	13.02M	0	0	9.94M	22.53M	16.43M	12.31M
R&D % of Revenue	1.61%	1.32%	1.36%	0.03%	-	-	0.07%	0.2%	0.12%	0.09%
Other Operating Expenses	42.2K	-1.66M	16.79K	78.94M	726.11K	0	0	0	0	0
Operating Income+	-30.95M	-31.01M	-18.85M	355.1M	-2.32M	84.5M	89.09M	42.7M	83.62M	69.98M
Operating Margin %	-3.79%	-2.07%	-1.54%	0.74%	-0.09%	0.68%	0.67%	0.39%	0.6%	0.5%
Operating Income Growth %	0.85%	-0%	0.39%	19.84%	-1.01%	37.39%	0.05%	-0.52%	0.96%	-0.16%
EBITDA+	-30.71M	-30.84M	-18.72M	355.17M	-1.8M	85.03M	89.62M	43.22M	84.16M	70.52M
EBITDA Margin %	-3.76%	-2.06%	-1.53%	0.74%	-0.07%	0.68%	0.67%	0.39%	0.6%	0.51%
EBITDA Growth %	0.85%	-0%	0.39%	19.98%	-1.01%	48.37%	0.05%	-0.52%	0.95%	-0.16%
D&A (Non-Cash Add-back)	247.36K	174.28K	132.19K	69.63K	527K	529.81K	522.37K	517.64K	538.29K	538.42K
EBIT	-38.72M	-25.62M	-23.57M	427.12M	5.59M	76.53M	89.09M	42.7M	83.62M	69.98M
Net Interest Income+	-266.73K	-14.06M	-14.76M	-15.48M	-15.77M	-3.02M	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	266.73K	14.06M	14.76M	15.48M	15.77M	3.02M	0	0	0	0
Other Income/Expense	-8.04M	-8.67M	-19.48M	56.54M	-7.86M	-10.99M	218.94K	1.43M	4.16M	6.09M
Pretax Income+	-38.99M	-39.68M	-38.33M	411.64M	-10.18M	73.51M	89.31M	44.13M	87.78M	76.07M
Pretax Margin %	-4.77%	-2.65%	-3.12%	0.86%	-0.38%	0.59%	0.67%	0.4%	0.63%	0.55%
Income Tax+	461.98K	13.88K	-2.09M	-10.17M	-2.94M	17.17M	19.86M	10.23M	19.71M	16.86M
Effective Tax Rate %	1.01%	1%	0.95%	1.02%	0.71%	0.77%	0.78%	0.77%	0.78%	0.78%
Net Income+	-39.45M	-39.7M	-36.24M	421.81M	-7.24M	56.34M	69.45M	33.9M	68.07M	59.21M
Net Margin %	-4.83%	-2.65%	-2.95%	0.88%	-0.27%	0.45%	0.52%	0.31%	0.49%	0.43%
Net Income Growth %	0.85%	-0.01%	0.09%	12.64%	-1.02%	8.78%	0.23%	-0.51%	1.01%	-0.13%
Net Income (Continuing)	-39.45M	-39.7M	-36.24M	421.81M	-7.24M	56.34M	69.45M	33.9M	68.07M	59.21M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.73	-0.69	-0.46	5.10	-0.09	0.71	0.91	0.46	0.95	0.83
EPS Growth %	0.85%	0.05%	0.33%	12.09%	-1.02%	9.06%	0.28%	-0.49%	1.07%	-0.13%
EPS (Basic)	-0.73	-0.69	-0.46	5.28	-0.09	0.71	0.92	0.46	0.95	0.83
Diluted Shares Outstanding	53.78M	57.19M	78.87M	82.71M	82.18M	79.44M	76.4M	73.55M	71.68M	71.77M
Basic Shares Outstanding	53.78M	57.19M	78.77M	79.92M	81.03M	79.26M	75.32M	72.93M	71.36M	71.25M
Dividend Payout Ratio	-	-	-	-	-	-	-	0.97%	0.47%	0.72%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	129.46M	69.16M	37.36M	121.29M	180.04M	143.61M	208.75M	185.79M	238.99M	231.04M
Cash & Short-Term Investments	112.71M	28.7M	19.86M	100.65M	65.25M	117.89M	103.14M	98.79M	150.15M	155.4M
Cash Only	112.71M	28.7M	19.86M	100.65M	65.25M	117.89M	103.14M	98.79M	150.15M	155.4M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	3.68M	3.15M	1.8M	1.96M	4.17M	3.34M	83.65M	45.41M	21.13M	21.17M
Days Sales Outstanding	164.14	76.82	53.61	1.5	56.89	9.76	228.42	149.61	55.12	55.69
Inventory	12.45M	26.21M	2.98M	2.91M	9.65M	20.27M	19.51M	39.27M	64.22M	49.56M
Days Inventory Outstanding	346	485.35	65.28	9.8	233.55	287.41	428.94	1.37K	1.31K	578.18
Other Current Assets	0	10.14M	10.7M	11.45M	95.74M	0	0	2.32M	3.5M	4.91M
Total Non-Current Assets+	56.27M	91.82M	107.31M	82.15M	18.52M	6.22M	5.97M	9.25M	15.36M	13.29M
Property, Plant & Equipment	449.82K	299.48K	138.64K	171.27K	2.62M	2.1M	2.37M	1.85M	1.33M	1.3M
Fixed Asset Turnover	18.18x	50.05x	88.50x	2785.33x	10.21x	59.39x	56.50x	59.93x	105.07x	106.84x
Goodwill	898.33K	898.33K	898.33K	898.33K	898.33K	898.33K	898.33K	898.33K	898.33K	898.33K
Intangible Assets	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	-212.71M	-213.42M	96.59M	68.29M	0	0	0	0	0	0
Other Non-Current Assets	1.99M	17.98M	7.24M	1.06M	856.77K	676.92K	286.58K	252.55K	2.08M	240.68K
Total Assets+	185.73M	160.98M	144.67M	203.44M	198.57M	149.83M	214.73M	195.04M	254.35M	244.34M
Asset Turnover	0.04x	0.09x	0.08x	2.34x	0.13x	0.83x	0.62x	0.57x	0.55x	0.57x
Asset Growth %	0.12%	-0.13%	-0.1%	0.41%	-0.02%	-0.25%	0.43%	-0.09%	0.3%	-0.04%
Total Current Liabilities+	7.33M	13.83M	6.81M	11.34M	91.74M	10.48M	30.49M	21.52M	54.12M	25.33M
Accounts Payable	3.94M	2.52M	1.33M	1.69M	3.05M	1.28M	2.03M	3.36M	1.46M	1.34M
Days Payables Outstanding	109.65	46.61	29.08	5.69	73.89	18.13	44.59	117.39	29.82	15.64
Short-Term Debt	0	0	0	0	80.04M	0	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	1.98M	8.69M	1.36M	5.03M	3.61M	3.42M	4.24M	3.66M	6.82M	3.07M
Current Ratio	17.65x	5.00x	5.49x	10.70x	1.96x	13.70x	6.85x	8.63x	4.42x	9.12x
Quick Ratio	15.96x	3.11x	5.05x	10.44x	1.86x	11.77x	6.21x	6.81x	3.23x	7.16x
Cash Conversion Cycle	400.5	515.56	89.82	5.61	216.54	279.04	612.77	1.41K	1.34K	618.24
Total Non-Current Liabilities+	462.83M	434.57M	461M	89.19M	9.05M	9.55M	9.92M	3.36M	3.38M	3.2M
Long-Term Debt	0	66.55M	71.05M	75.55M	0	0	0	0	0	0
Capital Lease Obligations	0	-26.84M	0	0	0	0	0	0	0	0
Deferred Tax Liabilities	265.64K	286.07K	11.47M	479.41K	0	0	0	0	0	0
Other Non-Current Liabilities	207.3M	-26.59M	12.31M	13.64M	9.05M	9.55M	9.92M	3.36M	3.38M	3.2M
Total Liabilities	470.16M	448.4M	467.81M	100.53M	100.78M	20.04M	40.41M	24.88M	57.49M	28.53M
Total Debt+	0	66.55M	71.05M	75.55M	80.46M	449.94K	466.83K	528.17K	564.01K	546.82K
Net Debt	-112.71M	37.85M	51.19M	-25.11M	15.22M	-117.44M	-102.67M	-98.26M	-149.58M	-154.85M
Debt / Equity	-	-	-	0.73x	0.82x	0.00x	0.00x	0.00x	0.00x	0.00x
Debt / EBITDA	-	-	-	0.21x	-	0.01x	0.01x	0.01x	0.01x	0.01x
Net Debt / EBITDA	-	-	-	-0.07x	-	-1.38x	-1.15x	-2.27x	-1.78x	-2.20x
Interest Coverage	-116.05x	-2.21x	-1.28x	22.94x	-0.15x	28.01x	-	-	-	-
Total Equity+	-284.43M	-287.42M	-323.14M	102.91M	97.78M	129.79M	174.31M	170.16M	196.86M	215.8M
Equity Growth %	-0.15%	-0.01%	-0.12%	1.32%	-0.05%	0.33%	0.34%	-0.02%	0.16%	0.1%
Book Value per Share	-5.29	-5.03	-4.10	1.24	1.19	1.63	2.28	2.31	2.75	3.01
Total Shareholders' Equity	-284.43M	-287.42M	-323.14M	102.91M	97.78M	129.79M	174.31M	170.16M	196.86M	215.8M
Common Stock	5.41K	7.87K	7.9K	8.08K	8.13K	7.72K	7.35K	7.27K	7.11K	7.14K
Retained Earnings	-461.44M	-501.14M	-537.38M	-115.79M	-123.03M	-95.19M	-51.76M	-63.8M	-38.94M	-22.84M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-3.3M	-3.47M	-3.35M	-3.24M	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	11.11M	-115.59M	-8.16M	68.87M	-18.2M	71.52M	11.49M	41.61M	94.8M	48.76M
Operating CF Margin %	1.36%	-7.71%	-0.66%	0.14%	-0.68%	0.57%	0.09%	0.38%	0.68%	0.35%
Operating CF Growth %	-0.22%	-11.4%	0.93%	9.44%	-1.26%	4.93%	-0.84%	2.62%	1.28%	-0.49%
Net Income	-39.45M	-39.7M	-36.24M	421.81M	-7.24M	56.34M	69.45M	33.9M	68.07M	59.21M
Depreciation & Amortization	247.36K	174.28K	132.19K	69.63K	527K	529.81K	522.37K	517.64K	538.29K	538.42K
Stock-Based Compensation	1.57M	775.54K	1.1M	2.27M	2.11M	1.35M	1.27M	1.78M	2.05M	3.64M
Deferred Taxes	243.71K	2.66M	-2.72M	-9.3M	-2.42M	11.61M	121.45K	-3.83M	-4.8M	193.42K
Other Non-Cash Items	10.05K	1.79M	21.23M	-348.87M	-593.99K	9.39M	501K	-199.19K	579.24K	-10.13M
Working Capital Changes	48.49M	-81.29M	8.34M	2.89M	-10.59M	-7.7M	-60.37M	9.44M	28.36M	-4.69M
Change in Receivables	-3.19M	522.36K	1.35M	-49.72K	-2.21M	827.73K	-80.31M	38.24M	24.28M	-35.18K
Change in Inventory	6.6M	-13.76M	22.69M	39	-6.74M	-8.01M	136.37K	-19.96M	-25.52M	15.34M
Change in Payables	1.86M	-177.34K	-1.85M	1.62M	936.84K	-2.2M	1.47M	2.07M	2M	-5.74M
Cash from Investing+	3.89M	1.19M	-100.12K	78.24M	-29.09K	-15.5K	-50.62K	0	-21.69K	-42.45K
Capital Expenditures	-108.95K	-23.93K	-100.12K	-102.26K	-29.09K	-15.5K	-50.62K	0	-21.69K	-42.45K
CapEx % of Revenue	0.01%	0%	0.01%	0%	0%	0%	0%	-	0%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	4M	1.21M	0	78.34M	0	0	0	0	0	0
Cash from Financing+	-2M	30.39M	-585.57K	-3.81M	-1.18M	-114.6M	-26.2M	-45.96M	-43.42M	-43.46M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	-32.94M	-32.14M	-42.67M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-3.33K	-32.9M	5.5K	-3.81M	-1.18M	-184.02K	-173.92K	-12.53K	-214.79K	-799.89K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	11M	-115.61M	-8.26M	68.77M	-18.23M	71.5M	11.44M	41.61M	94.78M	48.72M
FCF Margin %	1.35%	-7.71%	-0.67%	0.14%	-0.68%	0.57%	0.09%	0.38%	0.68%	0.35%
FCF Growth %	-0.22%	-11.51%	0.93%	9.33%	-1.27%	4.92%	-0.84%	2.64%	1.28%	-0.49%
FCF per Share	0.20	-2.02	-0.10	0.83	-0.22	0.90	0.15	0.57	1.32	0.68
FCF Conversion (FCF/Net Income)	-0.28x	2.91x	0.23x	0.16x	2.51x	1.27x	0.17x	1.23x	1.39x	0.82x
Interest Paid	0	11.67M	10.29M	0	0	0	0	0	0	0
Taxes Paid	0	500.98K	325K	251.96K	0	3.72M	1.06M	31.37M	3.5M	30.36M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-	409.86%	-7.22%	49.51%	45.68%	19.68%	37.09%	28.7%
Return on Invested Capital (ROIC)	-	-	-	342.28%	-1.83%	101.12%	159.1%	44.62%	105.25%	96.99%
Gross Margin	-60.6%	-31.51%	-35.95%	77.3%	43.59%	79.4%	87.58%	90.58%	87.26%	77.44%
Net Margin	-482.53%	-264.87%	-295.34%	88.42%	-27.08%	45.09%	51.96%	30.61%	48.65%	42.69%
Debt / Equity	-	-	-	0.73x	0.82x	0.00x	0.00x	0.00x	0.00x	0.00x
Interest Coverage	-116.05x	-2.21x	-1.28x	22.94x	-0.15x	28.01x	-	-	-	-
FCF Conversion	-0.28x	2.91x	0.23x	0.16x	2.51x	1.27x	0.17x	1.23x	1.39x	0.82x
Revenue Growth	160.39%	83.32%	-18.14%	3788.3%	-94.39%	367.28%	6.97%	-17.13%	26.31%	-0.86%

Revenue by Segment

	2018	2019	2022	2023	2024
Product Sales and Supportive Services	468.92M	11.19M	86.66M	130.67M	133.33M
Product Sales and Supportive Services Growth	-	-97.61%	674.45%	50.78%	2.04%
Research and Development	8.14M	15.55M	24.11M	9.25M	5.39M
Research and Development Growth	-	91.17%	55.05%	-61.64%	-41.73%

Revenue by Geography

	2018	2019	2022	2023	2024
UNITED STATES	-	-	39.8M	118.65M	115.74M
UNITED STATES Growth	-	-	-	198.09%	-2.45%
Non-US	-	-	70.97M	21.27M	22.98M
Non-US Growth	-	-	-	-70.03%	8.03%
Asia Pacific	-	-	14.85M	966.63K	13.86M
Asia Pacific Growth	-	-	-	-93.49%	1333.54%
EMEA	-	-	16.27M	20.3M	8.38M
EMEA Growth	-	-	-	24.77%	-58.72%
CANADA	-	-	38.88M	-	737.68K
CANADA Growth	-	-	-	-	-
Other	-	-	972.8K	-	-
Other Growth	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

SIGA Technologies, Inc. (SIGA) has a price-to-earnings (P/E) ratio of 8.0x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

SIGA Technologies, Inc. (SIGA) reported $172.2M in revenue for fiscal year 2024. This represents a 1254% increase from $12.7M in 2011.

SIGA Technologies, Inc. (SIGA) saw revenue decline by 0.9% over the past year.

Yes, SIGA Technologies, Inc. (SIGA) is profitable, generating $74.5M in net income for fiscal year 2024 (42.7% net margin).

Dividend & Returns

Yes, SIGA Technologies, Inc. (SIGA) pays a dividend with a yield of 8.99%. This makes it attractive for income-focused investors.

SIGA Technologies, Inc. (SIGA) has a return on equity (ROE) of 28.7%. This is excellent, indicating efficient use of shareholder capital.

SIGA Technologies, Inc. (SIGA) generated $116.3M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.